Hospital News and Research

RSS

Experimental cancer drug shows promise as a treatment for idiopathic pulmonary fibrosis

Researchers have shown that the medication saracatinib shows promise as a treatment for idiopathic pulmonary fibrosis (IPF).

13 Oct 2022

New technology for producing oxygen within cells

Oxygen is vital for life, and clinicians can provide supplemental oxygen to patients through face masks and nasal tubes, but there are no methods available for delivering oxygen directly into cells.

13 Oct 2022

Children who recover from sepsis are at risk of long-term health consequences, study finds

Even months after critical illness for sepsis, children are at risk for new or worsening medical conditions, a study suggests.

13 Oct 2022

Largest academic collaboration aims to transform the treatment for pediatric cancers

The Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute and St. Jude Children's Research Hospital today announced the largest academic collaboration of its kind to transform and accelerate the identification of vulnerabilities in pediatric cancers and translate them into better treatments.

13 Oct 2022

Potent antibiotic-loaded bone-cement could be used to treat bone infections

Each year, 700,000 people die due to antibiotic resistance. A growing global population unfortunately generates a growing resistance to established antibiotic treatments - a threat that has been met with insufficient funding and dwindling inspiration, as commercial incentives for developing new antibiotics have fallen.

13 Oct 2022

Changes in the skin microbiome may contribute to development of GVHD after stem cell transplant

Organ damage occurs in up to 70 percent of patients in the first few months following stem cell transplant. The precise reasons for this potentially life-threatening reaction have long been the subject of scientific research.

13 Oct 2022

Population-level cohort study evaluates efficacy and safety of all COVID-19 vaccines used in Denmark

In a new study, researchers investigated the long-term efficacy, safety, and durability of all severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines used in Denmark.

13 Oct 2022

The health status and exercise capacity of COVID-19 survivors one year after hospital discharge

A recent study evaluated the health status and exercise capacity of COVID-19-recovered patients one year after hospital discharge.

13 Oct 2022

Research project on female schistosomiasis receives record-high funding

Female genital schistosomiasis (FGS) is a disease that affects millions of women, but it is often misdiagnosed as cancer or a venereal disease. This leads to unnecessary surgery, social sanctions and ruined lives.

12 Oct 2022

Bionic pancreas effective at maintaining blood glucose levels in people with type 1 diabetes

A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with type 1 diabetes, a new multicenter clinical trial has found.

12 Oct 2022

Cardiovascular risk factors – not preexisting heart disease – are the main contributors to COVID-19 death

A national study suggests that risk factors for cardiovascular disease, such as age, smoking and diabetes – not preexisting heart disease – are the main contributors to death and poor outcomes for critically ill COVID-19 patients.

12 Oct 2022

Mass General Brigham’s mobile health services improved access to COVID-19 treatments for underserved populations

Two new papers from Mass General Brigham demonstrate the effectiveness of bringing COVID-19 health care services to where people need them the most.

12 Oct 2022

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo

A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC).

12 Oct 2022

Mic60-low gene signature may be a simple tool to estimate pancreatic cancer risk

The mitochondria is a key energy-producing component of the human cell that plays an important role in cancer cell metabolism.

12 Oct 2022

UQ-led study analyzes genetic variants that influence height

Children's growth will be easier to assess following a University of Queensland-led study analyzing the genetic variants that influence height.

12 Oct 2022

FUSCLEAN technology enables preventive cleaning of catheters and valves in patients with hydrocephaly

Researchers at the University of Seville and University Hospital Virgen del Rocío have published the results of the first successful test of a new technology created to prevent obstructions in catheters and valves (shunts) implanted in the brain of patients with hydrocephalus.

12 Oct 2022

Early skin-to-skin contact between mothers and premature babies has many benefits, study shows

Babies who are born two to three months early are usually separated from their mother in the first hours after birth.

12 Oct 2022

Scientists show how cellular hypoxia response increases fetal hemoglobin expression in adults

Scientists at St. Jude Children's Research Hospital have shown how a protein responsible for adapting to low oxygen conditions (hypoxia), causes increased expression of fetal hemoglobin (HbF) in adults.

12 Oct 2022

Inflammation and infection may predict post-thrombectomy mortality

In a new study, researchers assessed the association of markers of inflammation and infection with mortality in individuals with acute ischemic stroke post-thrombectomy.

12 Oct 2022

Molecular signature could be mechanistically related to bleeding risk after heart surgery

Postoperative bleeding is one of the most common complications after cardiac surgeries, especially in open heart ones. In this kind of surgery, surgeons need to resort to cardiopulmonary bypass, an extracorporeal circuit composed of tubes and machines that replicate the function of the heart and lungs.

12 Oct 2022

Hospital News and Research

Experimental cancer drug shows promise as a treatment for idiopathic pulmonary fibrosis

New technology for producing oxygen within cells

Children who recover from sepsis are at risk of long-term health consequences, study finds

Largest academic collaboration aims to transform the treatment for pediatric cancers

Potent antibiotic-loaded bone-cement could be used to treat bone infections

Changes in the skin microbiome may contribute to development of GVHD after stem cell transplant

Population-level cohort study evaluates efficacy and safety of all COVID-19 vaccines used in Denmark

The health status and exercise capacity of COVID-19 survivors one year after hospital discharge

Research project on female schistosomiasis receives record-high funding

Bionic pancreas effective at maintaining blood glucose levels in people with type 1 diabetes

Cardiovascular risk factors – not preexisting heart disease – are the main contributors to COVID-19 death

Mass General Brigham’s mobile health services improved access to COVID-19 treatments for underserved populations

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo

Mic60-low gene signature may be a simple tool to estimate pancreatic cancer risk

UQ-led study analyzes genetic variants that influence height

FUSCLEAN technology enables preventive cleaning of catheters and valves in patients with hydrocephaly

Early skin-to-skin contact between mothers and premature babies has many benefits, study shows

Scientists show how cellular hypoxia response increases fetal hemoglobin expression in adults

Inflammation and infection may predict post-thrombectomy mortality

Molecular signature could be mechanistically related to bleeding risk after heart surgery

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News